Tantipong Hutsaya, Morkchareonpong Chantana, Jaiyindee Songyod, Thamlikitkul Visanu
Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.
Infect Control Hosp Epidemiol. 2008 Feb;29(2):131-6. doi: 10.1086/526438.
To determine the effectiveness of oral decontamination with 2% chlorhexidine solution for the prevention of ventilator-associated pneumonia (VAP).
Randomized controlled trial and meta-analysis.
A tertiary care university hospital in Bangkok, Thailand.
Adult patients who received mechanical ventilation and who were hospitalized in intensive care units and general medical wards.
The patients were randomized to receive oral decontamination with 2% chlorhexidine solution or normal saline solution 4 times per day until their endotracheal tubes were removed. The outcome measures were the development of VAP and oropharyngeal colonization with gram-negative bacilli. Meta-analysis was performed by combining the results of the present study with those from another randomized controlled trial that also used a 2% chlorhexidine formulation for oral decontamination.
The characteristics of the patients in the chlorhexidine group (n=102) and the normal saline group (n=105) were not significantly different. The incidence of VAP in the chlorhexidine group was 4.9% (5 of 102), and the incidence in the normal saline group was 11.4% (12 of 105) (P=.08). The rate of VAP in the chlorhexidine group was 7 episodes per 1,000 ventilator-days, and the rate in the normal saline group was 21 episodes per 1,000 ventilator-days (P=.04). Irritation of the oral mucosa was observed in 10 (9.8%) of the patients in the chlorhexidine group and in 1 (0.9%) of the patients in the normal saline group (P=.001). Oropharyngeal colonization with gram-negative bacilli was either reduced or delayed in the chlorhexidine group. Overall mortality of the patients did not differ significantly between the groups. Meta-analysis of 2 randomized controlled trials revealed an overall relative risk of VAP for patients in the chlorhexidine group of 0.53 (95% confidence interval, 0.31-0.90; P=.02).
Oral decontamination with 2% chlorhexidine solution is an effective and safe method for preventing VAP in patients who receive mechanical ventilation.
确定使用2%氯己定溶液进行口腔去污预防呼吸机相关性肺炎(VAP)的有效性。
随机对照试验和荟萃分析。
泰国曼谷的一家三级护理大学医院。
接受机械通气并入住重症监护病房和普通内科病房的成年患者。
将患者随机分为两组,一组每天4次接受2%氯己定溶液进行口腔去污,另一组接受生理盐水溶液,直至拔除气管插管。观察指标为VAP的发生情况以及革兰氏阴性杆菌在口咽部的定植情况。通过将本研究结果与另一项同样使用2%氯己定制剂进行口腔去污的随机对照试验结果相结合进行荟萃分析。
氯己定组(n = 102)和生理盐水组(n = 105)患者的特征无显著差异。氯己定组VAP的发生率为4.9%(102例中有5例),生理盐水组为11.4%(105例中有12例)(P = 0.08)。氯己定组每1000个呼吸机日的VAP发生率为7例,生理盐水组为21例(P = 0.04)。氯己定组10例(9.8%)患者出现口腔黏膜刺激,生理盐水组1例(0.9%)患者出现(P = 0.001)。氯己定组革兰氏阴性杆菌在口咽部的定植减少或延迟。两组患者的总体死亡率无显著差异。两项随机对照试验的荟萃分析显示,氯己定组患者发生VAP的总体相对风险为0.53(95%置信区间,0.31 - 0.90;P = 0.02)。
对于接受机械通气的患者而言使用2%氯己定溶液进行口腔去污是预防VAP的一种有效且安全的方法。